Core Team
Dr Ashish Diwan Co-Founder
Dr Diwan has expertise in the three domains of surgical excellence, global research leadership and early-stage commercialisation challenges. He believes developing MedTech products requires not just an understanding but hands- on experience with IP landscaping, protections, regulatory & clinical affairs, intense and targeted R&D activities, Utilisation of the early research tax support and working with universities, ventures and strategic investors while at the same time maintaining high-level real-world patient practice contact and performing surgery. For over 22 years Dr Diwan has excelled in all these areas, his journey started following the Merrill Lynch Global Innovation award he received in New York following his PhD and fellowship training as a Spine & Scoliosis Surgeon at the Hospital for Special Surgery, Cornell University, New York NY. He is currently the Director of Spine Service and SpineLabs at the St George campus of the University of New South Wales.
Whilst running a busy surgical practise, he has been involved in numerous novel product development activities. With the help of federal grant funders and venture capital monies he has literally taken concepts from a piece of paper to human use. In the process he has had around two dozen patents as named inventor and understands the curious and difficult regulatory pathways involving drugs, devices and software-as-a-medical-device – he has led teams to clinical and commercial success.
Prof Ganga Prusty Professor Co-Founder
Gangadhara Prusty is a distinguished academic in UNSW’s Mechanical Engineering department, specialising in the advanced manufacturing of composite materials and biomaterials. His notable achievement includes the co-invention of innovative dental composites, now patented across major markets in the world. This innovation represents a significant breakthrough in the field of biomaterials.
Leading the Australian Composites Manufacturing CRC (ACM CRC) bid, Professor Prusty unified 33 partners in a transformative, decade-long (2023-2033) initiative valued at $250 million, showcasing his leadership in advancing the manufacturing automation of composites.
His scholarly contributions have earned him the prestigious “Australian Award for University Teaching,” reflecting his commitment to academic excellence. With over 300 published articles and a solid track record of mentoring 35 PhD students and over 40 Postdoctoral Fellows, he is recognised as a mentor who significantly contributes to the development of future engineering leaders.
At Setonix, Professor Prusty leverages his extensive knowledge to innovate biomaterial solutions for orthopaedic applications, ensuring the company remains at the forefront of technological advancements. His visionary leadership is vital to Setonix's global mission to transform biomaterials manufacturing.
Jayshri Bullen Chief Operating Officer
Jayshri has over 10 years commercial leadership experience and 15+ years working with leading spinal companies. She has extensive knowledge of the ANZ market, planned and driven strategic initiatives within organisations, and has developed, trained and lead successful sales teams across ANZ. Furthermore, her experience as a professional engineer designing, developing and adhering to regulatory compliance affords her a deep understanding of the medical device lifecycle.
As Chief Operating Officer at Setonix Technologies, she will be utilising her expertise in Strategic Planning and Market Creation of Spinal Fusion devices and Real-time monitoring solutions to bring the company’s patented technology to market.
Disclaimer:: Setonix Technologies’ products are not approved in any jurisdiction for clinical use. The System and the Device are investigational only at this stage and not available for commercial sale.